TY - JOUR JF - JMERC JO - Iran J War Public Health VL - 13 IS - 3 PY - 2021 Y1 - 2021/9/01 TI - Risk of Mortality due to Sudden Hyperglycemia in COVID-19 Patients TT - N2 - Aims: One of the most dangerous complications of COVID-19 is sudden hyperglycemia that may carry a high incidence of the death rate. This study aimed to evaluate the relationship between death rate and hyperglycemia caused by COVID-19 infection in non-diabetic patients. Materials & Methods: In this study, 296 patients were selected randomly, 57 patients complaining of sudden hyperglycemia (>400 mg/dl) one week after the high fever subsided; the others did not show such complain. Statistical analysis was done to evaluate the relative risk of hyperglycemia upon the incidence of mortality rate between two groups. Findings: The X2 value was 20.5959 for all, and the p-value was not significant except for COVID-19 with hyperglycemia that showed a highly significant mortality rate (X2=15.9, p<0.001). Conclusion: Hyperglycemia should be monitored even after regression of COVID-19 symptoms, and insulin therapy must be considered to minimize the risk of death. SP - 199 EP - 202 AU - Awad, W. AU - Kadhim, H.M. AU - Hassan, D.M. AU - Al-Yassiry, K.A.R. AD - Department of Biochemistry, College of Medicine, University of Kerbala, Kerbala, Iraq KW - COVID-19 KW - Hyperglycemia KW - Mortality Rate UR - http://ijwph.ir/article-1-992-en.html ER -